RISE, STABILIZE AND THRIVE

Dead / Abandoned — Abandoned — failure to respond (as of 14 Oct 2025)

What this means for you

This application is over — abandoned 29 Sept 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
98689783
Mark type
Stylized text
Filed
08 Aug 2024
Abandoned
29 Sept 2025
Attorney of record
Katharyn Bond

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of addiction to and abuse of alcohol, opiates, narcotics, food, sex, gambling, and other addictive or habit forming substances or behavior, for central nervous disorders, cancer, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular disease, circulatory system disease, intestinal disorders, obesity disease, diabetes disease, bone disease, autoimmune disorders and disorders of the immune systems, infectious disease and enzyme deficiency disease; implantable delivery systems comprised of a subcutaneous drug delivery device sold filled with sustainable release pharmaceutical preparations used in the treatment of addiction to and abuse of alcohol, opiates, narcotics, food, sex, gambling, and other addictive or habit forming substances or behavior, central nervous disorders and other serious and life-threatening diseases, cancer, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular disease, circulatory system disease, intestinal disorders, obesity disease, diabetes disease, bone disease, autoimmune disorders and disorders of the immune systems, infectious disease and enzyme deficiency disease; pharmaceuticals, namely, implantable drug delivery system comprised of a subcutaneous drug delivery device sold filled with a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction and diabetes disease; pharmaceuticals, namely, implantable drug delivery system comprised of a subcutaneous drug delivery device sold filled with a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening disease; Vitamins; Collagen for medical purposes; Hormone replacement therapy preparations

Owner

Prosecution history

  • 14 Oct 2025 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
  • 14 Oct 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
  • 27 Jun 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
  • 27 Jun 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
  • 28 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 28 Mar 2025 — NON-FINAL ACTION E-MAILED
  • 28 Mar 2025 — NON-FINAL ACTION WRITTEN
  • 24 Feb 2025 — ASSIGNED TO EXAMINER
  • 23 Feb 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
  • 12 Aug 2024 — NEW APPLICATION ENTERED

View this trademark record on Marksy